Menkes Disease: Copper-Histidine Therapy

J Gordon Millichap

doi:10.15844/pedneurbriefs-7-11-5

Menkes Disease: Copper-Histidine Therapy

Pediatric Neurology Briefs

Volume 7 (1993): Issue 11

By: J Gordon Millichap

Open Access

|Nov 1993

Abstract

The response to subcutaneous copper-histidine treatment (50 - 150 mcg Cu/kgm/daily) in seven children with Menkes disease (Kinky-Hair disease) is reported from the Hospital for Sick Children and University of Toronto, Canada.

References

Sarkar B Lingertat-Walsh K Clarke JTR Copper-histidine therapy for Menkes disease J Pediatr 1993 Nov 123 5 828 830 10.1016/S0022-3476(05)80870-4 8229500
Open DOI Search in Google Scholar Back to article
Kreuder J Otten A Fuder H Tumer Z Tonnesen T Horn N Clinical and biochemical consequences of copper-histidine therapy in Menkes disease Eur J Pediatr 1993 Oct 152 10 828 832 10.1007/BF02073380 8223785
Open DOI Search in Google Scholar Back to article
Harris ED Menkes disease: perspective and update on a fatal copper disorder Nutrition Reviews 1993 Aug 51 8 235 245 10.1111/j.1753-4887.1993.tb03111.x 8302493
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-7-11-5 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 84 - 85

Published on: Nov 1, 1993

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Menkes Disease,

Skeletal Deformities,

Infantile Spasms

© 1993 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 7 (1993): Issue 11